Darunavir/cobicistat

Details

Files

Generic Name:

Darunavir/cobicistat

Project Status:

Complete

Therapeutic Area:

HIV Infection

Manufacturer:

Janssen Inc.

Call for patient/clinician input open:

July 9, 2014

Brand Name:

Prezcobix

Project Line:

Reimbursement Review

Project Number:

SR0381-000

Call for patient/clinician input closed:

August 28, 2014

NOC Status at Filing:

Pre NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV Infection

Recommendation Type:

List with criteria/condition

Final Recommendation:

March 18, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : May 22, 2014